Patents by Inventor Georg DOESSINGER

Georg DOESSINGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240036053
    Abstract: The present invention relates to a method for treating cancer in a subject, comprising the step of administering to a subject in need thereof administering a therapeutically effective dose of a T cell capable of binding a neopeptide that is expressed by a tumor suppressor gene, wherein said neopeptide is derived from a frameshift product of a tumor suppressor gene and wherein the T cell binds to the neopeptide-MHC complex with a half-life (T1/2) of at least 50 s.
    Type: Application
    Filed: February 27, 2023
    Publication date: February 1, 2024
    Applicant: TECHNISCHE UNIVERSITAET MUENCHEN
    Inventors: Markus GERHARD, Dirk BUSCH, Georg DOESSINGER, Antonius SCHUMACHER, Carsten LINNEMANN
  • Publication number: 20180088121
    Abstract: The present invention relates to a method for providing a neopeptide-specific T cell, wherein the neopeptide-specific T cell forms a complex having a half-life (T½) of at least 50 s with a neopeptide-MHC monomer. The present invention further relates to a T cell obtainable by the method as well as a pharmaceutical composition comprising such T cells.
    Type: Application
    Filed: March 31, 2016
    Publication date: March 29, 2018
    Applicant: TECHNISCHE UNIVERSITAET MUENCHEN
    Inventors: Markus GERHARD, Dirk BUSCH, Georg DOESSINGER, Antonius SCHUMACHER, Carsten LINNEMANN